Oncolytics Biotech Inc. (ONCY) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 7.49M | 6.84M | 14.05M | 18.9M | 18.49M | 18.88M | 22.91M | 30.63M | 33.38M | 38.17M | 45.34M | 31M | 34.26M | 35.68M | 38.21M | 39.41M | 43.54M | 44.9M | 51.59M | 55.44M |
| Cash & Short-Term Investments | 5.49M | 5.2M | 12.35M | 14.63M | 15.3M | 15.94M | 19.6M | 24.85M | 29.6M | 34.91M | 39.98M | 24.35M | 29.67M | 32.14M | 32.36M | 33.69M | 39.48M | 41.26M | 48.09M | 50.8M |
| Cash Only | 5.49M | 5.2M | 12.35M | 14.63M | 15.3M | 15.94M | 19.6M | 24.85M | 29.6M | 34.91M | 39.98M | 17.52M | 15.87M | 11.67M | 32.36M | 33.69M | 39.48M | 41.26M | 48.09M | 50.8M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.83M | 13.8M | 20.47M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 961K | 573K | 54K | 72K | 89K | 68K | 104K | 1.57M | 102K | 15K | 630K | 559K | 0 | 521K | 0 | 0 | 0 | 866K | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 1.02M | 1.22M | 980K | 1.09M | 848K | 623K | 0 | 0 | 0 | 730K | 0 | 496.86K | 355.61K | 102.22K | 0 | 251.32K | 135.86K |
| Total Non-Current Assets | 674K | 738K | 1.01M | 1.08M | 1.22M | 1.31M | 1.35M | 1.44M | 1.37M | 647K | 752K | 971K | 1.07M | 1.65M | 753.71K | 831.87K | 910.71K | 976K | 1M | 870.38K |
| Property, Plant & Equipment | 674K | 738K | 1.01M | 1.08M | 1.22M | 1.31M | 1.35M | 1.44M | 1.37M | 647K | 752K | 744K | 840K | 652K | 753.71K | 831.87K | 910.71K | 976K | 1M | 870.38K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 227K | 227K | 998K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 8.16M | 7.58M | 15.06M | 19.97M | 19.7M | 20.19M | 24.26M | 32.07M | 34.75M | 38.82M | 46.09M | 31.97M | 35.33M | 37.33M | 38.96M | 40.24M | 44.45M | 45.88M | 52.59M | 56.31M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -58.58% | -62.44% | -37.94% | -37.72% | -43.3% | -48% | -47.36% | 0.32% | -1.64% | 3.98% | 18.3% | -20.56% | -20.52% | -18.63% | -25.92% | -28.54% | -17.97% | 33.58% | 68.34% | 62.72% |
| Total Current Liabilities | 5.42M | 6.1M | 7.66M | 6.56M | 5.77M | 6.69M | 7.66M | 6.14M | 4.1M | 4.24M | 10.02M | 2.65M | 2.47M | 3.94M | 3.67M | 2.54M | 2.42M | 2.69M | 2.71M | 2.58M |
| Accounts Payable | 0 | 3.5M | 4.2M | 1.33M | 779K | 1.09M | 3.43M | 886K | 744K | 1.08M | 2.19M | 629K | 528K | 2.25M | 3.32M | 2.18M | 2.05M | 594K | 2.33M | 2.19M |
| Days Payables Outstanding | - | - | - | - | - | - | - | 1.04K | 675.47 | 1.41K | 1.69K | 736.5 | 1.74K | 3.52K | 3.38K | 2.52K | 1.54K | 1.75K | 3.11K | 1.4K |
| Short-Term Debt | 166K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 5.26M | 2.4M | 199K | 982K | 530K | 1.62M | 489K | 1.26M | 314K | 532K | 5.29M | 153K | 48K | 79K | 50.03K | 31.36K | 68.23K | 408K | 106.06K | 153.97K |
| Current Ratio | 1.38x | 1.12x | 1.84x | 2.88x | 3.21x | 2.82x | 2.99x | 4.99x | 8.14x | 9.01x | 4.53x | 11.69x | 13.88x | 9.05x | 10.42x | 15.49x | 17.96x | 16.69x | 19.04x | 21.47x |
| Quick Ratio | 1.38x | 1.12x | 1.84x | 2.88x | 3.21x | 2.82x | 2.99x | 4.99x | 8.14x | 9.01x | 4.53x | 11.69x | 13.88x | 9.05x | 10.42x | 15.49x | 17.96x | 16.69x | 19.04x | 21.47x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.87M | 5.28M | 7.29M | 7.33M | 7.44M | 7.52M | 7.54M | 7.62M | 7.68M | 7.02M | 7.05M | 7.08M | 7.11M | 6.89M | 6.9M | 6.92M | 7.01M | 7.09M | 7.17M | 7.24M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 342K | 370K | 557K | 597K | 710K | 787K | 813K | 891K | 948K | 290K | 323K | 346K | 378K | 157K | 165.92K | 192.09K | 276.64K | 361K | 441.98K | 510.37K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.62M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.73M | 0 | 6.73M | 6.73M | 6.73M | 0 | 6.73M | 6.73M |
| Total Liabilities | 13.29M | 11.38M | 14.94M | 13.88M | 13.21M | 14.2M | 15.21M | 13.76M | 11.78M | 11.26M | 17.07M | 9.73M | 9.58M | 10.83M | 10.56M | 9.47M | 9.43M | 9.78M | 9.88M | 9.82M |
| Total Debt | 508K | 563K | 835K | 888K | 1M | 1.06M | 1.06M | 1.12M | 1.13M | 423K | 514K | 479K | 567K | 373K | 460.78K | 522.44K | 584.12K | 655K | 710.74K | 744.51K |
| Net Debt | -4.99M | -4.64M | -11.52M | -13.74M | -14.3M | -14.88M | -18.53M | -23.73M | -28.48M | -34.49M | -39.47M | -17.04M | -15.3M | -11.29M | -31.9M | -33.17M | -38.9M | -40.61M | -47.38M | -50.05M |
| Debt / Equity | - | - | 7.26x | 0.15x | 0.15x | 0.18x | 0.12x | 0.06x | 0.05x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | -5.13M | -3.8M | 115K | 6.09M | 6.49M | 5.98M | 9.06M | 18.31M | 22.97M | 27.56M | 29.02M | 22.24M | 25.75M | 26.5M | 28.4M | 30.77M | 35.02M | 36.1M | 42.71M | 46.49M |
| Equity Growth % | -179% | -163.5% | -98.73% | -66.75% | -71.73% | -78.29% | -68.79% | -17.66% | -10.8% | 4% | 2.19% | -27.73% | -26.46% | -26.59% | -33.52% | -33.8% | -21.61% | 45.84% | 103.67% | 93.78% |
| Book Value per Share | -0.05 | -0.04 | 0.00 | 0.07 | 0.08 | 0.08 | 0.12 | 0.24 | 0.31 | 0.37 | 0.42 | 0.34 | 0.41 | 0.45 | 0.49 | 0.53 | 0.62 | 0.66 | 0.78 | 0.86 |
| Total Shareholders' Equity | -5.13M | -3.8M | 115K | 6.09M | 6.49M | 5.98M | 9.06M | 18.31M | 22.97M | 27.56M | 29.02M | 22.24M | 25.75M | 26.5M | 28.4M | 30.77M | 35.02M | 36.1M | 42.71M | 46.49M |
| Common Stock | 0 | 0 | 458.63M | 451.14M | 445.53M | 438.19M | 434.46M | 434.55M | 432.51M | 430.91M | 428.83M | 413.42M | 409.41M | 404.04M | 398.07M | 396.81M | 396.5M | 391.35M | 391.17M | 391.12M |
| Retained Earnings | -438.74M | -429.5M | -504.96M | -490.56M | -484.4M | -477.71M | -469.7M | -460.15M | -452.9M | -446M | -442.05M | -432.13M | -424.69M | -418.25M | -409.7M | -405.29M | -400.19M | -393.42M | -385.66M | -380.79M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 6.22M | 6.22M | 789K | 720K | 958K | 961K | 653K | 722K | 670K | 544K | 655K | 554K | 659K | 662K | 722.63K | 453.24K | 3.96M | 388K | 4.02M | 3.93M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |